This article first appeared on GuruFocus.

Nike (NYSE:NKE) is facing another warning from Wall Street, with UBS cutting its price target to $42 from $48 as deteriorating sales trends raise the risk of weaker earnings and another reset to fiscal 2027 expectations.

UBS analyst Jay Sole maintained a Neutral rating but said the firm’s recent channel checks show Nike’s global sales growth trend has worsened over the past three months.

UBS Sends Stark Warning to Nike Stock Investors NKE GF Value chart

That comes with shares already under heavy pressure.

Nike recently traded around $35.78, just above its 52-week low of $35.76, and the stock has fallen roughly 49% over the past year.

UBS expects Nike to miss fiscal first-quarter 2027 earnings estimates by about 5 cents per share.

More importantly, the firm expects management to provide an implied fiscal second-quarter EPS outlook of roughly 31 cents to 43 cents, well below the Street’s current 53-cent estimate.

UBS also sees a risk that Nike uses the upcoming earnings report to lower fiscal 2027 expectations ahead of its November investor day.

The firm believes investors remain too optimistic about the magnitude of potential earnings revisions.

According to UBS, the next report could push Wall Street EPS estimates lower and further weaken sentiment.

Options markets appear prepared for significant volatility, pricing in an approximately 8% move around the event compared with Nike’s historical average move of about 6.7%.

Investors Takeaway

The key risk is that the stock’s nearly 50% decline has not yet fully captured the deterioration in earnings.

That matters because low share prices alone do not create a valuation floor if profit estimates continue moving lower.

UBS is effectively arguing that Nike could face another leg of estimate cuts before the turnaround becomes visible.

Investors should watch global sales trends, gross margins, fiscal 2027 guidance and management’s November investor-day strategy.

The bull case is that expectations have already fallen dramatically, creating room for upside if sales stabilize.

The bearish case is that Nike’s earnings base keeps shrinking faster than the stock’s valuation adjusts.

With Morgan Stanley, BMO and UBS all highlighting downside risks, the next earnings report could become an important test of whether Nike’s turnaround is merely slow or still deteriorating.